Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-08

Clinical Trial Update: BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BuCY versus TBICY conditioning regimens for standard-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUCY
  • TBICY

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan | Phase 3 | Status: COMPLETED